GT Metabolic Solutions

GT Metabolic Solutions

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://gtmetabolic.com

Last Round

Series B

Nov 6, 2023

Total Funding Raised

$32.1M

Momentum Score

75 /100

Company Overview

GT Metabolic Solutions, Inc. is a medical device company founded in 2020 that specializes in developing magnetic compression anastomosis technologies for minimally invasive procedures in bariatric, metabolic, and digestive surgery. The company's flagship product is the MagDI™ System, an FDA-cleared platform that enables an incisionless, sutureless, and staple-free technique for creating a connection (anastomosis) in the gastrointestinal tract. This technology is designed to reduce complications like leaks and bleeds compared to traditional methods, leaving no foreign material behind as the magnets are naturally passed from the body. The company aims to democratize and improve the safety of surgical approaches to anastomosis for both patients and healthcare providers. GT Metabolic has secured Series A and Series B funding to support clinical trials and the commercial launch of its products in the U.S. and international markets.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

endoscopic bariatric therapynon-surgical bariatric surgerybariatric medical deviceincisionless bariatric surgeryendoscopic weight lossnon-surgical weight lossobesity treatmentminimally invasive surgerymetabolic surgery alternativetype 2 diabetes treatmentincisionless anastomosistransoral endoscopic therapygastric sleeve alternativegastric bypass alternativegastroenterology deviceMagDI System

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GT Metabolic Solutions Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GT Metabolic Solutions Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BNov 6, 2023
Series AJul 18, 2022

Key People

Founding team and executive leadership

Thierry Thaure

Chief Executive Officer

Executive Team

GT Metabolic Solutions Investors

Notable investors and investment history

InvestorRounds
HealthTech CapitalSeries B
Krillion VenturesSeries B
Ceros Capital MarketsSeries B, Series A

GT Metabolic Solutions Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GT Metabolic Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GT Metabolic Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range21
Year Founded2020
Last FundingNov 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.